Chemoproteomics reveals berberine directly binds to PKM2 to inhibit the progression of colorectal cancer
Shihai Yan, Li-Mu Hu, Xue-Hui Hao, Jiang Liu, Xiying Tan, Zhirong Geng, Jing Ma, Zhilin Wang
Abstract
-O triangular structure of berberine contributed to hydrophobic interaction with I119 amino acid residues and π-π interaction with F244 amino acid residues of PKM2 protein. Moreover, berberine was shown to inhibit the reprogramming of glucose metabolism and the phosphorylation of STAT3, down regulate the expression of Bcl-2 and Cyclin D1 genes, ultimately inhibiting the progression of colorectal cancer. This study uncovered the direct binding target protein and mechanism of berberine to improve metabolic reprogramming in colorectal cancer, which is helpful to guide the optimization of berberine.
Topics & Concepts
BerberinePKM2Colorectal cancerCancer researchChemistryBiochemistryColorectal adenomaCancerPyruvate kinaseMetabolismBiologyMedicineInternal medicineGlycolysisBerberine and alkaloids researchSynthesis and Biological ActivityChromatography in Natural Products